کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
69470 | 48771 | 2015 | 4 صفحه PDF | دانلود رایگان |

• (R)-2-(anthracen-9-yl)-2-methoxyacetic acid was obtained using the reduction α-ketoester.
• Enzymatic reduction was carried out using Saccharomyces cerevisiae and Aureobasidium pullulans.
• Antimycotic agent Boni Protect containing live A. pullulans cells is the best catalyst.
Optically pure (R)-2-(anthracen-9-yl)-2-methoxyacetic acid ((R)-9-AMA) was obtained. The most important stage of the synthesis generating chirality and ensuring high enantioselectivity was the stage of desymmetrization of prochiral α-ketoester. Enzymatic biotransformation was used in the presence of Saccharomyces cerevisiae and Aureobasidium pullulans. Biotransformation using S. cerevisiae leads to 65–70% enantiomeric excess (R-isomer). The antimycotic agent Boni Protect containing live cells of A. pullulans allowed to obtain enantiomerically pure (R)-9-AMA.
Figure optionsDownload as PowerPoint slide
Journal: Journal of Molecular Catalysis B: Enzymatic - Volume 121, November 2015, Pages 28–31